We congratulate the winners of the Investigator Awards to their presentation during the
3rd EAN Congress in Amsterdam 2017!
The Prize consists of an Award certificate and free registration to the Lisbon Congress.
All winners’ presentations were filmed – just click on the winner’s name to see the video or find all videos here: https://www.ean.org/amsterdam2017/Investigator-Award.3694.0.html
Flavio Nobili, Italy
Abstract title:
Incremental value of automated assessment of FDG-PET compared to visual reading, in the diagnostic work-up of patients with dementing neurodegenerative disorders
Moira Marizzoni, Italy
Abstract title:
Negative association between peripheral blood NLRP3 levels and CA1 and subiculum in MCI patients with AD pathology: an innate immune pathway leading to hippocampal neurodegeneration
Nadine Pelzer, The Netherlands
Abstract title:
Circulating endothelial markers in the monogenic small vessel disease Retinal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifestations
Eva Zupanic, Slovenia
Abstract title:
Outcomes of thrombolysis treatment in patients with dementia and acute ischemic stroke A longitudinal cohort study from SveDem and Riksstroke, Swedish Dementia and Stroke Registries
Liselore Mensing, The Netherlands
Abstract title:
Rupture risk for familial compared to sporadic intracranial aneurysms
Yael Hacohen, United Kingdom
Abstract title:
Diagnostic algorithm for relapsing inflammatory demyelinating syndromes of the central nervous system in children
Emerlinda De Meo, Italy
Abstract title:
Regional Grey Matter Atrophy in Pediatric Patients with Multiple Sclerosis: A Longitudinal MRI Study
+ Regional patterns of brain atrophy development in pediatric and adult multiple sclerosis patients: a 3.5 year study
Eline M. C. Hamilton, The Netherlands
Abstract title:
The natural history of Vanishing White Matter
Laura Licchetta, Italy
Abstract title:
Genetics of Sleep-related Hypermotor Epilepsy (SHE): Whole Exome Sequencing (WES) in a large Italian cohort
Uwe Reuter, Germany
Abstract title:
Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Primary Results of the STRIVE Trial
Simona Brajkovic, Italy
Abstract title:
Antisense oligonucleotides-based therapy as a promising therapy for Amyotrophic Lateral Sclerosis
Emily Feneberg, United Kingdom
Abstract title:
Multicenter evaluation of neurofilaments in early symptomatic amyotrophic lateral sclerosis
Elena Antelmi, Italy
Abstract title:
Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder
Piotr Sowa, Norway
Abstract title:
Restriction spectrum imaging in multiple sclerosis
Ettore Salsano, Italy
Abstract title:
Adult-onset hypomyelinating leukodystrophies: a clinical and genetic study of 15 individuals
Matthijs van der Meulen, The Netherlands
Abstract title:
Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015
Nadia Younan, France
Abstract title:
Isolated intra-ocular relapses of primary central nervous system lymphoma
Mark Stettner, Germany
Abstract title:
Corneal Confocal Microscopy as Surrogate Marker in Inflammatory Neuropathies
Ivo van Schaik, The Netherlands
Abstract title:
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the PATH Study
Maxime Baud, Switzerland
Abstract title:
Seizures are locked to multidien rhythms in epilepsy
